Jounce Therapeutics, Inc.
Antibodies to PD-1 and uses thereof

Last updated:

Abstract:

Provided herein are various embodiments relating to antibodies. Some of the embodiments include antagonist antibodies that bind PD-1. Such antibodies can be used in methods to treat, for example, cancer.

Status:
Grant
Type:

Utility

Filling date:

1 Nov 2017

Issue date:

19 May 2020